JNJ – johnson & johnson (US:NASDAQ)
Stock Stats
News
3/5
04:06 pm
jnj
Low
Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line [Yahoo! Finance]
3/5
03:59 pm
jnj
Low
Johnson & Johnson (JNJ) had its price target raised by JPMorgan Chase & Co. from $225.00 to $250.00. They now have a "neutral" rating on the stock.
3/5
03:55 pm
jnj
Low
Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line
3/5
01:29 pm
jnj
Low
The Top High Yield ETFs Every Retiree Should Own [Yahoo! Finance]
3/5
12:27 pm
jnj
Low
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]
1/21/2026
06:20 am
JNJ
1.4%
BEAT
10/14/2025
06:20 am
JNJ
0.1%
BEAT
7/16/2025
06:20 am
JNJ
5.1%
BEAT
4/15/2025
06:20 am
JNJ
-1.2%
BEAT
3/5
03:56 pm
Maintains
Neutral
Neutral
JP Morgan
Low
0.0%
3/2
09:02 pm
Reiterates
Neutral
Neutral
Bank of America Corporation
Low
-0.9%
2/3
11:09 am
Maintains
Outperform
Outperform
RBC Capital
Low
-0.2%
2/3
11:09 am
Maintains
Outperform
Outperform
RBC Capital
Low
-0.2%
1/28
06:26 am
Upgrades
Equal-Weight
Overweight
Morgan Stanley
Low
1.3%
3/3
04:26 pm
jnj
Low
Form 4 JOHNSON & JOHNSON For: Feb 27 Filed by: Decker Robert J
2/27
02:35 pm
jnj
Low
Form 144 JOHNSON & JOHNSON Filed by: Decker Robert J
2/23
05:20 pm
jnj
Low
Form 4 JOHNSON & JOHNSON For: Feb 20 Filed by: Schmid Timothy
2/20
10:46 am
jnj
Low
Form 144 JOHNSON & JOHNSON Filed by: Schmid Timothy
2/18
09:13 pm
jnj
Low
Form 4 JOHNSON & JOHNSON For: Feb 13 Filed by: Swanson James D.
Show more
Top News Gainers
3/27 Form DEFA14A JOHNSON & JOHNSON 8.1%
3/12 Paul Harris' Top Picks: March 12, 2020 [Business News Network (BNN) Energy & Resources (Canada)] 7.5%
4/7 Is JNJ Stock A Buy On CEO's Bullish Call For Coronavirus Vaccine? [Investor's Business Daily] 4.6%
4/5 Will These 3 Coronavirus Stocks Lead the Market to Recovery? [Yahoo! Finance News] 4.3%
4/13 Stocks slip as market enters new phase, with investors worrying about balance sheets [CNBC] 4.0%
3/2 AODocs Joins AIIM Leadership Council, Showcases Innovative Approach to Information Management at 2020 AIIM Conference 3.9%
3/4 Johnson & Johnson ordered to pay $1.7 million to three Australian women in pelvic mesh class action [Reuters] 3.8%
3/18 Is This 1 Healthcare Stock Coronavirus-Proof? [The Motley Fool] 3.8%
3/24 What Technology And Manufacturing Can Do To Help Against COVID-19 [Forbes] 3.6%
4/1 5 of the Best Stocks to Buy for April [Yahoo! Finance News] 3.3%
Top News Decliners
3/21 Johnson and Johnson: A Safe Haven in Recession [The Motley Fool] -7.3%
3/20 Is Johnson & Johnson (NYSE:JNJ) Trading At A 35% Discount? [Yahoo! Finance News] -6.9%
3/10 J&J MET antibody nabs accelerated review status for certain lung cancer patients [Seeking Alpha] -6.8%
3/18 J&J files U.S. application for MS med ponesimod [Seeking Alpha] -6.6%
10/18 Wolves In Sheep’s Clothing: We Can’t Trust Businesses To Do Right By Americans Now [Forbes] -6.4%
5/28 Oklahoma taking on Johnson & Johnson in historic trial [MSNBC.com] -6.1%
3/13 Americans rush to stock up on essentials as coronavirus spreads [Reuters] -5.5%
3/11 Desperate to exit, a $10B price tag for Magic Leap is crazy [TechCrunch Blog] -4.9%
7/12 Johnson & Johnson (NYSE: JNJ) is now covered by analysts at Credit Suisse Group AG. They set an "outperform" rating and a $156.00 price target on the stock. -4.5%
3/6 Eyecare industry leaders sign Proclamation to focus on key issues facing the future of optometry -3.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3